Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SMALL CELL LUNG CARCINOMA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT03447769
What this trial is testing

Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A

Who this might be right for
Non-Small Cell Lung Cancer
Novartis Pharmaceuticals 1,382
Large-scale testing (Phase 3)Ended earlyNCT00003803
What this trial is testing

Chemotherapy Plus Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Cannot Be Surgically Removed

Who this might be right for
Lung Cancer
European Organisation for Research and Treatment of Cancer - EORTC 158
Testing effectiveness (Phase 2)Study completedNCT02450903
What this trial is testing

LDK378 in Patients With ALK Positive NSCLC Previously Treated With Alectinib.

Who this might be right for
Non-Small-Cell Lung Cancer
Novartis Pharmaceuticals 20
Testing effectiveness (Phase 2)Ended earlyNCT00858403
What this trial is testing

Dasatinib in Advanced Non-small Cell Lung Cancer (NSCL) With Ex Vivo and In Vivo Assessment of Tumor Target Modulation

Who this might be right for
Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute 7
Early research (Phase 1)Looking for participantsNCT05136846
What this trial is testing

Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung Cancer

Who this might be right for
Locally Advanced Lung Non-Small Cell CarcinomaStage II Lung Cancer AJCC v8Stage IIA Lung Cancer AJCC v8+6 more
Ohio State University Comprehensive Cancer Center 28
Testing effectiveness (Phase 2)Ended earlyNCT03026166
What this trial is testing

Rovalpituzumab Tesirine Administered in Combination With Nivolumab and With or Without Ipilimumab for Adults With Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
AbbVie 42
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06648200
What this trial is testing

Toripalimab and JS004 Combined With Platinum-based Chemotherapy for Relapsed and Extensive-stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer Extensive StageSmall Cell Lung Cancer Recurrent
Shanghai Pulmonary Hospital, Shanghai, China 100
Early research (Phase 1)Looking for participantsNCT07416695
What this trial is testing

A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HLX3901 in Patients With Advanced SCLC or NEC

Who this might be right for
SCLCNEC
Shanghai Henlius Biotech 138
Not applicableStudy completedNCT03885765
What this trial is testing

Complication and Lung Function Impairment Prediction Using Perfusion and CT Air Trapping

Who this might be right for
Non-small Cell Lung Cancer
University Hospital, Montpellier 160
Testing effectiveness (Phase 2)Looking for participantsNCT07632365
What this trial is testing

Induction Chemoimmunotherapy in Combination With Chemoradiotherapy and Consolidation Immunotherapy in Unresectable Locally Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerLocally Advanced Non-Small Cell Lung CancerUnresectable Stage III NSCLC
Shanghai Chest Hospital 108
Not applicableNot Yet RecruitingNCT07163507
What this trial is testing

Immune Response to Immunotherapy in Lung Cancer: Study of Sputum and Blood Samples

Who this might be right for
Lung Cancer (NSCLC)Lung Cancer (Non-Small Cell)
University Hospital, Tours 50
Testing effectiveness (Phase 2)Study completedNCT00004139
What this trial is testing

Gemcitabine Plus Docetaxel or Irinotecan in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 80
Large-scale testing (Phase 3)UnknownNCT02859077
What this trial is testing

EGFR-TKI With Chemotherapy in NSCLC Patients With Both EGFR Mutation and BIM Deletion Polymorphism

Who this might be right for
Non-Small-Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 100
Not applicableStudy completedNCT05740501
What this trial is testing

Pharmacokinetic Profiling of Pembrolizumab and Nivolumab in Patients With Melanoma and/or Non-Small Cell Lung Cancer

Who this might be right for
Lung Non-Small Cell CarcinomaMelanoma
Mayo Clinic 13
Not applicableStudy completedNCT00899028
What this trial is testing

Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy Participants

Who this might be right for
Lung Cancer
Vanderbilt University Medical Center 689
Testing effectiveness (Phase 2)Study completedNCT00063219
What this trial is testing

Study Evaluating MAC-321 in Non-small Cell Lung Cancer Refractory to Platinum-based Therapy

Who this might be right for
Carcinoma, Non-Small-Cell LungLung Neoplasms
Wyeth is now a wholly owned subsidiary of Pfizer 48
Large-scale testing (Phase 3)Study completedNCT00061919
What this trial is testing

Carboplatin and Etoposide With or Without Thalidomide in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
University College, London 724
Early research (Phase 1)WithdrawnNCT02451865
What this trial is testing

Binimetinib With Docetaxel in Treating Patients With Previously Treated, Stage IV Non-small Cell Lung Cancer

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage IV Non-Small Cell Lung Cancer
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02797977
What this trial is testing

A Phase 1/2 Trial SRA737 in Combination With Gemcitabine and Cisplatin or Gemcitabine Alone in Advanced Cancer Subjects

Who this might be right for
Advanced Solid Tumors
Sierra Oncology LLC - a GSK company 153
Early research (Phase 1)Study completedNCT02447900
What this trial is testing

Marker Guided Breathhold Radiotherapy in NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Steen Riisgaard Mortensen 15
Next Page